Kurema-kurasikirwa nemushonga Belviq akabviswa mumusika weUS mukati mezvinonetsa zvinomutsa kenza njodzi

Nhau

Musi waFebruary 13, Eisai , ivo vanogadzira uremu-kurasikirwa nemushonga Belviq uye Belviq XR (lorcaserin HCI), akazvipira kubvisa mushonga kubva kumusika weU.S. pakukumbira kwa US Chikafu neDrug Administration (FDA) . Belviq imishonga yemishonga, inowanikwa sehwendefa uye piritsi rekuburitsa-rakawedzerwa. Inowedzera manzwiro ekuzara kubatsira varwere kudya zvishoma uye kurasikirwa nehuremu hwakawanda, kunyanya kana uchishandiswa pamwe nekudya uye kurovedza muviri. Iyo FDA yakabvumidza Belviq muna 2012 kune vanhu vakuru vakafutisa; kana avo vakafuta uye vane matambudziko ekurapa ane chekuita nehuremu, akadai seshuga, BP, kana cholesterol yakawanda.

Sei FDA yakumbira kubviswa kwaBelviq?

Sechikamu chekubvumidzwa kwekushambadzira kwaBelviq, iyo FDA yaida kuti Eisai aedze kuyedza kwenguva yakareba achiongorora kana mushonga uyu wakaburitsa chero matambudziko emwoyo muvashandisi. Chidzidzo chakatora makore mashanu uye chakatarisa vashandisi zviuru gumi nezviviri vane chirwere chemwoyo uye / kana njodzi yakanyanya yekuve nechirwere chemoyo. Yakaona kuti mushonga uyu, zvirokwazvo, unobatsira vashandisi kudzikira uremu vasina kuburitsa chero hombe matambudziko emoyo.

Asi pakuongorora iyo data, iyo FDA yakaona kuti vanhu vanotora Belviq vane huwandu hwakanyanya hwecancer kupfuura avo vasina kutora mushonga. Zvinoenderana neongororo yeDFA, 7.7% yevashandisi veBelviq vakawanikwa vaine gomarara panguva yekudzidza, vachipesana ne7.1% yeavo vari muboka rekutonga avo vaitora placebo (piritsi risingashande raive risina chero mushonga). Mhando dzekenza dzaisanganisira pancreatic, colorectal, uye kenza yemapapu. Kunyange kambani ichiti kududzirwa kwayo kwe data kwakasiyana neiyo FDA, iyo FDA inoti njodzi dzekushandisa Belviq dzinopfuura bhenefiti yayo.

Eisai anoremekedza danho reDAA uye ari kushanda padhuze neiyo Sisitimu panzira yekubvisa, ikambani yakati mune chirevo .

Chii chinofanirwa kuitwa nevashandisi veBelviq?

Iyo FDA inonyevera vashandisi kuti varege kutora Belviq nekukurumidza uye vokurukura dzimwe nzira dzekurema-kurasikirwa nachiremba wavo. Belviq anoshanda zvakasiyana pane imwe yekurema-kurasikirwa nemishonga pamusika, saka zvinogoneka chiremba wako anogona kuraira kushandisa imwe mishonga kana kukurudzira kudya uye kurovedza muviri wega.

Kuti ubvise zvisina kushandiswa Belviq zvakanaka, uya nemishonga kune zvinodhaka kutora-kumashure nzvimbo . Kana izvo zvisingaite, iyo FDA inokurudzira kuti ubvise Belviq mumarara:

• Bvisa mushonga mubhodhoro rekurapa wobva wasanganisa nechinhu chisingafadzi - semuenzaniso, marara ekatsi kana nzvimbo yekofi yakashandiswa. Usapwanya mahwendefa.
• Isa musanganiswa wemishonga muhomwe yepurasitiki yakavharika.
• Rasa mudziyo pamwe nemarara emumba mako.
• Bvisa chitupa chako kubva mubhodhoro rekurapa uye wochidzokororazve kana kuchirasa zvakare.

Ini ndinoda kuwedzerwa kenza kuongororwa?

Kwete. Iyo FDA haisi kudaidzira chero yekuwedzera kenza kuongororwa kwevashandisi veBelviq kupfuura izvo zvatove kurairwa kune veruzhinji. Vashandisi havafanirwe kuvhunduka, anodaroShaili Gandhi, Pharm.D., Mutevedzeri wemutungamiriri wezve formulary mashandiro kuSingleCare. Varwere vanofanirwa kutaura navanachiremba pamusoro pemibvunzo kana zvinonetsa zvavanogona kunge vainazvo. Iyo hurukuro inofanirwa kusanganisira imwe nzira yekurapa sarudzo uye nzira dzekudzikisa uremu.

Varwere kana vatapi vezvehutano vanogona kumhan'arira chero nyaya kuDAA's MedWatch Kudzivirirwa Ruzivo uye Yakashata Chiitiko Kuzivisa Chirongwa na kuendesa online mushumo kana nekufona 1-800-332-1088.